1Hormestam B, Cartsson T, Falk L, et al. Effocts of intravenously administered Digoxin in acute atrial fibrillation, compared to placebo(Abstr)[J].Circulation, 1995,92:1 - 774.
2Lerr A J,Simmonds MB, Stewart RAH.Influende of heart rate on stroke volume variability in atrial fibrillation in patients with normal and impaired left ventricular function[J] .Am J Cardiol, 1992,82:496 - 500.
3Bouhour JB.Digitalis and beta-blockers:what treatment,what dose and for which patient[J]? Arch Mal Coeur Vaiss,2000,93:17- 21.
4Krahn AD, Manfreda J,Tate RB, et al.The natural history of atrial fibrillation: incidence, risk factors,and prognosis in the Mannitoba follow-up study[J]. Am J Med, 1995,98:466 - 488.
5Van den Berg MP,Tuinenberg AE, Crijns HJGM, et al.Heart failure and atrial fibrillation:current concepts and coetroverstes[ J ]. Heart, 1997,77:309-313.
6Goldenberg IF,Lewis WR, Dias VC, et al.Intravenous diltiazem for the treatment of the patients with atrial fibrillation of flutter and moderate to severe congestive cardiac failure[J].Am J Cardiol, 1994,74:884 - 889.
